Join
Live feed
·
NEWSReleasevia Quantisnow
Sonoma Pharmaceuticals Inc. logo

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

ByQuantisnow·Wall Street's wire, on your screen.
SNOA· Sonoma Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNOA (Sonoma Pharmaceuticals Inc.) and more on Quantisnow.